Sept 29 (Reuters) – Eli Lilly said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial. (
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Kanishka Singh WASHINGTON, Sept 29 (Reuters) - President Donald Trump released a document on…
One day after acquiring Kirill Marchenko in a blockbuster trade on the eve of the…
By Kanishka Singh WASHINGTON, Sept 29 (Reuters) - President Donald Trump released a document on…
(Adds Xeris response in paragraph 3, analyst comment in paragraph 7) Sept 29 (Reuters) -…
VIDEO SHOWS: INTERVIEW WITH STEFAN BORSON, HEAD OF SPORT AT MCCARTHY DENNING, ON MANCHESTER CITY…
Sept 29 (Reuters) - Goldman Sachs' private credit fund said on Tuesday that investor requests…